|
HS Code |
641274 |
| Chemicalname | 2-Amino-6-Hydroxy-8-Mercaptopurine |
| Molecularformula | C5H5N5OS |
| Molecularweight | 183.20 g/mol |
| Casnumber | 366-67-2 |
| Appearance | Light yellow to yellow-green solid |
| Meltingpoint | 200-205°C (decomposes) |
| Solubility | Slightly soluble in water |
| Purity | Typically ≥98% |
| Storageconditions | Store at 2-8°C, protected from light and moisture |
| Synonyms | 8-Mercapto-2-aminoxantine |
| Pubchemcid | 28146 |
As an accredited 2-Amino-6-Hydroxy-8-Mercaptopurine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 10 grams of 2-Amino-6-Hydroxy-8-Mercaptopurine, labeled with product details, hazard symbols, and storage instructions. |
| Shipping | 2-Amino-6-Hydroxy-8-Mercaptopurine is shipped in tightly sealed containers to prevent moisture and light exposure. It is packed according to chemical safety regulations, with proper labeling and cushioning. The package includes a Safety Data Sheet and complies with all local and international transport guidelines for hazardous materials. |
| Storage | 2-Amino-6-Hydroxy-8-Mercaptopurine should be stored in a tightly closed container, protected from light and moisture. Keep it in a cool, dry place, away from incompatible substances such as strong oxidizing agents. For optimal stability, store at temperatures between 2-8°C (refrigerated). Ensure proper labeling and access controls to avoid accidental exposure or contamination. |
Applications of 2-Amino-6-Hydroxy-8-Mercaptopurine in Industrial Manufacturing2-Amino-6-Hydroxy-8-Mercaptopurine serves as a specialized active ingredient and intermediate for pharmaceutical, biochemical, diagnostics, and chemical synthesis industries. The following sections detail specific industrial applications, with precise integration points, compliance details, and downstream product outputs. 1. Active Pharmaceutical Ingredient (API) Synthesis for Antiviral Drug ManufacturingThis compound acts as a key nucleobase intermediate for antiviral drug synthesis, especially in the development of purine analogues for pharmaceuticals targeting viral replication. The substance enters as a nucleoside intermediate in multi-step synthesis of active pharmaceutical compounds. Manufacturers focus on high-purity crystallization to meet narrow specification profiles for downstream pharmaceutical integration. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Diagnostic Oligonucleotide Probe SynthesisIn molecular diagnostics, the compound acts as a structural purine source in the custom synthesis of modified oligonucleotides and nucleotide probes. Integration requires controlled protection and deprotection steps during solid-phase synthesis protocols to ensure correct base incorporation and high probe fidelity. Quality management prioritizes traceability and batch reproducibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Reference Standard ProductionThe compound is processed into analytical reference materials for pharmaceutical quality control and regulatory validation. Strict documentation ensures full auditable traceability from raw material through to the finished reference standard. Calibration against pharmacopeial guidelines is critical to ensure suitability for HPLC and GC assay validation in drug quality laboratories. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Biochemical Reagent Manufacturing for Research UseUsed as a purine analog for biochemical research, this compound is provided as a reagent-grade material for incorporation in enzyme assays, nucleic acid metabolism studies, and cell culture experiments. Focus during production lies on maintaining batch-to-batch reproducibility, high lot purity, and low trace metal content to meet laboratory and industrial R&D needs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Amino-6-Hydroxy-8-Mercaptopurine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In chemical manufacturing, every product reflects a long chain of deliberate decisions and hands-on monitoring. As a manufacturer directly involved with 2-Amino-6-Hydroxy-8-Mercaptopurine, our attention stays on much more than just producing a viable compound. Under the lens: choosing the right synthesis pathway, rigorous purification, and continuous quality checks. Our laboratory teams use established synthetic chemistry methods, and they also watch for subtle shifts batch to batch. Handling delicate reactions, controlling temperatures and pH levels, and tracking the purity after crystallization—these steps take skill coupled with real patience, and every mishap teaches something new.
We don’t adopt a generic attitude. Each batch gets charted and archived, with more eyes on strange color shifts or unexpected points in chromatography or spectroscopy. The crystalline powder, usually off-white, gets checked for residual solvent, moisture, and traces of reactant. Yields and purities fluctuate in early runs, and those lessons go right into the process notes. Year after year, the feedback from our technical division and customer labs pushes us to revisit and, when necessary, tweak the core process.
In practice, 2-Amino-6-Hydroxy-8-Mercaptopurine stands out among purine derivatives for a peculiar blend of solubility and reactivity. Our process, using select solvents and miniaturized filtration steps, manages to consistently turn out powder with high purity—as verified by NMR, HPLC, and elemental analysis in-house. This allows for confident deployment in research and early lead compound studies.
Distinct from its cousins like mercaptopurine or thioguanine, this molecule features both the mercapto and hydroxy substitution pattern. Chemists take notice of this for its ability to take part in targeted hydrogen bonding and sulfur-based interactions. This opens possibilities in nucleoside analogue construction and as a building block for custom adducts. Over years, our technical chemists found that while similar purines tend toward rapid degradation under heat or light, 2-Amino-6-Hydroxy-8-Mercaptopurine stores relatively well when shielded from humidity and oxygen. The balance of electron-rich and -poor centers leads to interesting reactivity in both nucleophilic and electrophilic substitutions—a fact that keeps attracting project inquiries from medicinal and bioorganic teams.
Lab researchers and scale-up groups approach us monthly about solvents, solubility limits, and compatibility with protecting groups. We hear recurring themes—ease of dissolving in DMSO and DMF is a frequent point, as is the mild odor typical with mercapto groups. Some users have reported issues with aggregate formation in aqueous buffers; for these, we offer protocols showing best results under nitrogen atmosphere and mild base addition.
As a company that manufactures at kilo scale, we’ve watched the granular challenges emerge. Direct feedback suggests that heating above 80°C reduces purity, and repeated long-term exposures to unbuffered acidic conditions catalyze decomposition. Our standard advice grows from these hard-earned findings: process under minimal light, use amber-glass containers, and minimize open-air exposure during weighing and transfer.
In larger research groups, the molecule’s dual site reactivity allows for different modifications: for example, activating the thiol or reacting the amino group independently, giving versatile entry points into more elaborate synthesis. Some customers have compared their workups with ours and noted our material withstands longer stirring times, which comes down to particle size and the absence of trace oxidants from upstream steps. Over the years, scaling up from grams to kilos took determination. Early clumping, inconsistent drying, and invisible traces of side-products taught us what patience plus verification—GC-MS scans, Karl Fischer titrations for water, spot-check TLCs—can achieve.
The applications of 2-Amino-6-Hydroxy-8-Mercaptopurine seem to cross boundaries. A significant portion of our recurring customers operate in pharmaceutical research, most often targeting novel antimetabolite scaffolds. In recent studies, this molecule acted as a precursor in the synthesis of more complex analogues, with researchers focusing on selective enzyme inhibition or modulating DNA repair pathways. Synthetic organic groups find value in its two reactive handles, customizing substitution based on site-selective needs.
Occasionally, we hear from academic chemists investigating nucleic acid mimics. The hydroxy and mercapto substitutions support hydrogen bonding in ways standard purine analogues do not, which sometimes helps in forming stable complexes for probing biological recognition events. In another field, biochemists keep asking about compatibility with enzyme systems or bioconjugation protocols. Our response comes straight from batch records and collaborative testing: stability holds under moderate pH and ambient conditions, but rapid changes in environment risk promoting side-reactions such as oxidation at the sulfhydryl group.
Some scientists in the field of agricultural biotechnology have also tried novel applications, such as studies on plant cell division inhibitors, or labeling with isotopic tracers. These collaborations prompt us to regularly examine the fine details of purity and trace contaminants, whether it’s residual acids from the workup or microquantities of phosphorus, which can influence biological experiments. We maintain an emphasis on transparent, ongoing dialogue—often sending out additional spectra or running third-party impurity checks at customer request.
Every year, clients approach us after experimenting with standard purine drugs, wanting to know what difference this product can make. Our main observation: 2-Amino-6-Hydroxy-8-Mercaptopurine brings greater dual reactivity, which expands synthetic options. Comparative studies show its hydroxy group enables selective activation not available in simple mercaptopurines. High-performance liquid chromatography (HPLC) runs consistently reveal higher retention compared to 6-mercaptopurine, for instance, indicating a shift in hydrophilic-lipophilic balance—an important detail in formulation.
Processing experience reveals more: some purine analogues suffer severe oxidative discoloration during storage or shipment, but after our refinement of the crystallization and drying process, batches consistently arrive with the same off-white, free-flowing appearance. We log stability checks quarterly, monitoring for change in melting point and purity via HPLC and NMR. Unlike bulkier nucleoside analogues, this product easily dissolves in moderate volumes of common organic solvents, making it a reliable choice for reactions requiring precise stoichiometry and uniform dispersion.
A visible difference appears in analytical work. Many alternative compounds show complicated baseline drifts, possible overlaps with commonly used excipients or processing aids. In-house analysts report that our 2-Amino-6-Hydroxy-8-Mercaptopurine produces clean, sharp peaks in chromatograms—a validation of both our synthetic pathway and post-synthesis handling. These apparently small distinctions improve method development and reduce troubleshooting for downstream researchers.
Our approach to manufacturing chemical building blocks always returns to honest conversation. Customers often seek details beyond a product label: What purification methods do you rely on? How do you monitor for stability under various storage conditions? Each answer stems from day-to-day experience. Every year brings new requests—from changes in batch size to tailored purification protocols—pushing us to keep our production nimble and responsive.
Returning customers from major research institutes or biotech startups reach out with new demands, sometimes wanting extra physical characterization or early shipment to fit tight deadlines. We keep a rolling inventory, split into research and pilot-scale batches, letting smaller labs avoid long lead times even as our largest bulk shipments go abroad. Through these interactions, we learn where even small process tweaks can matter. One season, aggressive vacuum drying actually introduced static cling, making precise dosing difficult—a detail solved by adopting a controlled nitrogen atmosphere during packaging and switching to anti-static containers.
Problems always arise. Early batches sometimes contained residual solvent levels just over threshold—solved by extending drying cycles but keeping temperature just below decomposition point. A run of clumping during shipment prompted us to rethink our packaging; switching to micro-perforated pouches inside amber jars lowered clumping and reduced waste on arrival. As requests for larger batches grew, inconsistent batch color highlighted traces of side-products. Our chemists collaborated directly with QC staff, running brief small-scale syntheses to test the effect of every change, tweaking the acid-to-solvent ratio, checking if trace iron contamination from older vessels contributed. Changes weren’t always blueprints from literature—they emerged from trial, feedback, and repeated hands-on assessment.
Customer complaints echo through our manufacturing records. One account detailed a problem with batch-to-batch melting point drift detected during scale-up reactions; we traced it to a slight difference in the temperature gradient across drying equipment, corrected by re-calibrating and adding redundant thermocouples. We record these stories not as failures, but as hard-won guides for future process changes. Over the course of many annual site inspections and external audits, we open our process logs and analytical sheets to outside eyes, building trust through honest disclosure and continuous process adjustment.
A recurring request in recent years targets full analytical traceability. Our customers ask for spectra, impurity profiles, and even batch production notes showing when a run started and ended. We keep a comprehensive digital archive of NMR, IR, UV-vis spectra, and detailed HPLC traces for every batch since 2018, granting access to customers whose methods demand a deeper look. This stems from our belief that a good reputation grows from more than one-on-one calls or email chains—it comes from always being ready to stand behind both the product and the process. If a researcher’s results stray from expectations, we offer new test lots and additional analytical checks as a sign of confidence in our own track record.
Not every user has the same needs: pharmaceutical researchers may want full validation paperwork, while academic labs want to see high concentration solubility trials. Our staff rotate between roles, often consulting on unusual requests: custom particle sizing, specific storage temperatures, stability data across months and seasons. Experience shows that flexibility strengthens long-term business relationships, even more than detailed paperwork or certifications.
Producing any specialty chemical means staying aware of both regulatory standards and environmental impact. In our daily work with 2-Amino-6-Hydroxy-8-Mercaptopurine, compliance with applicable regulatory guidance forms the baseline, but so does practical waste management. Employees trained in safe handling and processing protocols report potential hazards—from acid splashes to risk of thiol odor exposure—so we invest in routine audits, updated safety equipment, and regular improvement meetings.
From the beginning, solvent recycling and efficient use of raw materials reduced waste. Reaction optimization targets minimized byproduct formation, which improves both economics and environmental profile. Over-oxidation or uncontrolled neutralizations used to generate additional wash waste, but tighter process parameters dropped that sharply. We work with approved disposal partners for all hazardous waste, tracking receipts and aiming to demonstrate clear environmental good practice—further appreciated by larger, sustainability-conscious research organizations who ask about lifecycle data. Tightening these controls does not just check regulatory boxes—it means easier repeatability for everyone using the product, fewer surprises, and a safer working environment for our staff.
Years of hands-on experience keep urging us towards better solutions. Feedback cycles with end-users—sometimes new requests for specific batch modifications, sometimes troubleshooting issues surfaced in the field—inform every meeting our technical and sales teams hold. We keep looking for the small improvements: refining drying protocols based on season, monitoring packaging shifts for shipping to varying climates, updating solvents used based on new analytical findings or regulatory changes.
Experimental crowd-sourcing—having external groups collaborate on pilot batches, involving them in scaled pilot processes—has steered product evolution. There were missteps through the years, and occasional costly discoveries, but openness with clients ensures the quickest path to a stable, reliable supply chain. Satisfaction does not rest on protocols alone; it’s the practical willingness to answer direct questions from chemists, biologists, and formulation teams alike.
At its core, the work with 2-Amino-6-Hydroxy-8-Mercaptopurine builds on our drive to foster trust throughout every stage, from synthesis to delivery. Each batch represents a chapter in responsiveness, adaptation, and improvement, ensuring our customers do not just receive a purine derivative, but a source of reliable functionality and insight, grounded in evolving field experience.